AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4. A total of 24 filers reported holding AERIE PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,636,000 | -52.9% | 1,672,000 | -59.4% | 0.00% | -100.0% |
| Q2 2022 | $3,473,000 | -9.8% | 4,117,000 | -3.6% | 0.00% | 0.0% |
| Q1 2022 | $3,852,000 | +13.4% | 4,269,000 | +5.6% | 0.00% | 0.0% |
| Q4 2021 | $3,397,000 | +10.1% | 4,044,000 | +17.8% | 0.00% | 0.0% |
| Q3 2021 | $3,086,000 | +6.8% | 3,434,000 | +17.0% | 0.00% | – |
| Q2 2021 | $2,890,000 | -4.2% | 2,934,000 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $3,016,000 | +10.6% | 2,934,000 | -1.4% | 0.00% | 0.0% |
| Q4 2020 | $2,727,000 | +55.0% | 2,975,000 | +36.2% | 0.00% | – |
| Q3 2020 | $1,759,000 | – | 2,185,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 157,390,000 | $143,842,000 | 2.81% |
| PFM Health Sciences, LP | 48,150,000 | $44,256,000 | 1.30% |
| DAFNA Capital Management LLC | 1,500,000 | $1,375,000 | 0.36% |
| SILVERBACK ASSET MANAGEMENT LLC | 2,500,000 | $2,303,000 | 0.34% |
| Context Capital Management, LLC | 2,979 | $2,707,000 | 0.28% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 9,667,000 | $8,842,000 | 0.16% |
| DeepCurrents Investment Group LLC | 3,700,000 | $3,423,000 | 0.10% |
| LOOMIS SAYLES & CO L P | 1,249,328 | $14,242,000 | 0.02% |
| SG Americas Securities, LLC | 22,600 | $2,255,000 | 0.01% |
| LAZARD ASSET MANAGEMENT LLC | 9,218,000 | $8,376,000 | 0.01% |